Skip to search formSkip to main contentSkip to account menu

bulaquine

Known as: CDRI 80-53, N'-(3-acetyl-4,5-dihydro-2-furanyl)-N(4)-(6-methoxy-8-quinolyl)-1,4-pentanediamine 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Primaquine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
New Antimalarial Drug Discovery in India and Future Strategy for Malaria Control
This INSA commissioned report on “New antimalarial drug discovery in India and future strategy for malaria control” focuses on… 
Review
2006
Review
2006
ymposium Malaria : Antimalarial resistance and policy ramifications and challenges
Department of Clinical ABSTRACT Pharmacology, Seth G S ‘The National Health Policy 2002” of India and the “Roll Back Malaria… 
2006
2006
A COMBINATION KIT USED IN THE TREATMENT OF MALARIA CONTAINING CHLOROQUINE AND BULAQUINE
  • 2006
  • Corpus ID: 116870494
2005
2005
Plasmodium cynomolgi: gametocytocidal activity of the anti-malarial compound CDRI 80/53 (elubaquine) in rhesus monkeys.
2005
2005
A randomized, parallel group, study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adult patients of acute uncomplicated falciparum malaria
Background The study was carried out to assess the efficacy of a single dose of 45 mg primaquine versus 75 mg Bulaquine as a… 
2001
2001
Comparative antirelapse efficacy of CDRI compound 80/53 (Bulaquine) vs primaquine in double blind clinical trial
One-year follow-up of malaria patients was undertaken to monitor the antirelapse efficacy of CDRI compound 80/53 (Bulaquine). A… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)